Search

Your search keyword '"Baas, A. F."' showing total 437 results

Search Constraints

Start Over You searched for: Author "Baas, A. F." Remove constraint Author: "Baas, A. F."
437 results on '"Baas, A. F."'

Search Results

2. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study

4. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy

8. Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients

10. Mitochondrial Cardiomyopathies

11. Genotype-phenotype correlation in pseudoxanthoma elasticum

12. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study

13. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.

14. BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

15. Influence of stressful life events and personality traits on PLN cardiomyopathy severity:an exploratory study

16. Influence of stressful life events and personality traits on PLN cardiomyopathy severity: an exploratory study

17. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study

18. The Genetic Basis of Apparently Idiopathic Ventricular Fibrillation – a Retrospective Overview

19. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

22. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies

23. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy

30. Variants in members of the cadherin–catenin complex, CDH1 and CTNND1, cause blepharocheilodontic syndrome

31. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

32. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

33. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

34. The genetic basis of apparently idiopathic ventricular fibrillation:A retrospective overview

35. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity:an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

36. The Genetic Basis of Apparently Idiopathic Ventricular Fibrillation - a Retrospective Overview

37. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy

38. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

39. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

40. Penetrance and Prognosis of MYH7Variant-Associated Cardiomyopathies

41. Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population

42. Meta‐analysis of individual‐patient data from EVAR‐1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years

46. Long-term survival and secondary procedures after open or endovascular repair of abdominal aortic aneurysms

50. Surveillance and monitoring in vascular Ehlers-Danlos syndrome in European Reference Network For Rare Vascular Diseases (VASCERN)

Catalog

Books, media, physical & digital resources